lercanidipine, calcium channel blocker of the third generation: new possibilities in the treatment of arterial hypertension
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

lercanidipine, calcium channel blocker of the third generation: new possibilities in the treatment of arterial hypertension

;O. D. Ostroumova;M. L. Maksimov;I. I. Kopchenov
environmental technology 2015 Vol. 9 pp. 79-85
142
ostroumova2015racionalnalercanidipine,

Abstract

Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lercanidipine are detailed.

Keywords

pharmacologydiseases of the circulatory (cardiovascular) system антигипертензивная терапия

Access

DOI:
10.1234/1819-6446-2013-1-79-85
URL:
http://www.rpcardio.ru/jour/article/view/77

Citation

ID: 246918
Ref Key: ostroumova2015racionalnalercanidipine,
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
246918
Unique Identifier:
10.1234/1819-6446-2013-1-79-85
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store